J. Jaime

Active 1979–2024

106
Papers
25,082
Citations
86
h-index
102
i10-index

Citations

Citations per year for J. Jaime1945: 1 citations1979: 1 citations1981: 5 citations1982: 4 citations1983: 3 citations1984: 5 citations1985: 5 citations1986: 2 citations1987: 9 citations1988: 8 citations1989: 26 citations1990: 21 citations1991: 30 citations1992: 30 citations1993: 47 citations1994: 40 citations1995: 38 citations1996: 29 citations1997: 64 citations1998: 76 citations1999: 96 citations2000: 125 citations2001: 169 citations2002: 171 citations2003: 192 citations2004: 198 citations2005: 215 citations2006: 216 citations2007: 197 citations2008: 232 citations2009: 194 citations2010: 188 citations2011: 237 citations2012: 251 citations2013: 202 citations2014: 184 citations2015: 209 citations2016: 180 citations2017: 173 citations2018: 183 citations2019: 516 citations2020: 531 citations2021: 472 citations2022: 361 citations2023: 212 citations2024: 363 citations2025: 137 citations2026: 10 citations1946–1978: no citations, so these years are not shown1980: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,509 citing papers, 27.6% of this breakdownUnited Kingdom: 837 citing papers, 9.2% of this breakdownChina: 557 citing papers, 6.1% of this breakdownCanada: 478 citing papers, 5.3% of this breakdownGermany: 451 citing papers, 5% of this breakdownAustralia: 355 citing papers, 3.9% of this breakdownNetherlands: 334 citing papers, 3.7% of this breakdownItaly: 299 citing papers, 3.3% of this breakdownFrance: 258 citing papers, 2.8% of this breakdownSwitzerland: 249 citing papers, 2.8% of this breakdownSpain: 215 citing papers, 2.4% of this breakdownJapan: 209 citing papers, 2.3% of this breakdown
0%27.6%Other 25.6%

Fields

  • Medicine52%
  • Biochemistry, Genetics and Molecular Biology32.6%
  • Economics, Econometrics and Finance3.4%
  • Immunology and Microbiology2.8%
  • Health Professions2.3%
  • Neuroscience1.1%
  • Other5.8%

Topics

  • Cancer, Hypoxia, and Metabolism8.8%
  • Musculoskeletal pain and rehabilitation2.4%
  • Health Systems, Economic Evaluations, Quality of Life2.3%
  • Erythropoietin and Anemia Treatment2.1%
  • Mitochondrial Function and Pathology1.7%
  • Angiogenesis and VEGF in Cancer1.5%
  • Other81.2%

Coauthors

All papers

Open in search
  1. A systematic review of low back pain cost of illness studies in the United States and internationally

    Authors: , , - The Spine Journal 2008 cited by 2,064

  2. Hypoxia-inducible Factor 1α (HIF-1α) Protein Is Rapidly Degraded by the Ubiquitin-Proteasome System under Normoxic Conditions

    Authors: , - Journal of Biological Chemistry 1997 cited by 1,656

  3. Modeling Good Research Practices—Overview: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1

    Authors: , , , - Value in Health 2012 cited by 755

  4. Budget Impact Analysis—Principles of Good Practice: Report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force

    Authors: , , , , , , , , , - Value in Health 2013 cited by 1,169

  5. Model Transparency and Validation

    Authors: , , , , , - Medical Decision Making 2012 cited by 791

  6. Modeling Good Research Practices—Overview

    Authors: , , , - Medical Decision Making 2012 cited by 511

  7. Autophagy in cancer associated fibroblasts promotes tumor cell survival

    Authors: , , , , , , , , , , , , , , , , - Cell Cycle 2010 cited by 416

  8. The importance of patient-reported outcomes: a call for their comprehensive integration in cardiovascular clinical trials

    Authors: , , , , , , , , , , , , - European Heart Journal 2014 cited by 364

  9. Prediction of Recurrent Ischemic Stroke Using Registry Data and Machine Learning Methods: The Erlangen Stroke Registry

    Authors: , , , , , , - Stroke 2022 cited by 41

  10. Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review.

    Authors: , , , - 2001 cited by 849

  11. Principles of Good Practice for Budget Impact Analysis: Report of the ISPOR Task Force on Good Research Practices—Budget Impact Analysis

    Authors: , , , , , , , , - Value in Health 2007 cited by 752

  12. Model Transparency and Validation: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-7

    Authors: , , , , , - Value in Health 2012 cited by 460

  13. MAPK Signaling Up-regulates the Activity of Hypoxia-inducible Factors by Its Effects on p300

    Authors: , , , , , - Journal of Biological Chemistry 2003 cited by 367

  14. Anemia as an independent prognostic factor for survival in patients with cancer

    Authors: , , , - Cancer 2001 cited by 765

  15. Hypoxic regulation of the 6‐phosphofructo‐2‐kinase/fructose‐2,6‐bisphosphatase gene family (PFKFB‐1–4) expression in vivo

    Authors: , , - FEBS Letters 2003 cited by 234

  16. Modeling using Discrete Event Simulation: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-4

    Authors: , , , , , - Value in Health 2012 cited by 238

  17. Hypoxia-inducible Factor-1-mediated Expression of the 6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3) Gene

    Authors: , , , , , , - Journal of Biological Chemistry 2002 cited by 364

  18. HIF1-alpha functions as a tumor promoter in cancer-associated fibroblasts, and as a tumor suppressor in breast cancer cells

    Authors: , , , , , , , , , , , , , - Cell Cycle 2010 cited by 229

  19. Modeling Using Discrete Event Simulation

    Authors: , , , , , - Medical Decision Making 2012 cited by 337

  20. 6-Phosphofructo-2-kinase (pfkfb3) Gene Promoter Contains Hypoxia-inducible Factor-1 Binding Sites Necessary for Transactivation in Response to Hypoxia

    Authors: , , , , , , , , , - Journal of Biological Chemistry 2004 cited by 281

  21. Regulation of endothelin-1 gene expression in human microvascular endothelial cells by hypoxia and cobalt: Role of hypoxia responsive element

    Authors: , - Molecular and Cellular Biochemistry 2000 cited by 123

  22. TP53 Induced Glycolysis and Apoptosis Regulator and Monocarboxylate Transporter 4 drive metabolic reprogramming with c‐MYC and NFkB activation in breast cancer

    Authors: , , , , , , , , , , , - International Journal of Cancer 2023 cited by 26

  23. Assessing the Value of Healthcare Interventions Using Multi-Criteria Decision Analysis: A Review of the Literature

    Authors: , , , , - PharmacoEconomics 2014 cited by 288

  24. Overexpression of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-4 in the human breast and colon malignant tumors

    Authors: , , , , , , , - Biochimie 2005 cited by 111